Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torcetrapib/Atorvastatin Efficacy and Safety in Mixed Dyslipidemia
NCT00138762Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2004
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of torcetrapib in mixed dyslipidemia, sponsored by Pfizer. Started Jul 2004; status: completed.
02
Drugs
torcetrapib
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00138762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138762.